Frontiers in Clinical Drug Research – Anti Allergy Agents

Author(s): Aysa Rezabakhsh and Hassan Soleimanpour * .

DOI: 10.2174/9789815040616122050007

Cite As
Aspirin Desensitization/Challenge in Patients with Cardiovascular Diseases: Current Trends and Advances

Pp: 147-189 (43)

Buy Chapters
Add to Cart

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Aspirin, known as acetylsalicylic acid (ASA), is one of the most commonly
used medications. Available as over-the-counter medicine, ASA is prescribed as a
nonsteroidal anti-inflammatory and anti-platelet drug and has the potential to decrease
pain and fever. ASA is also considered as a first-line drug for the treatment of some
cardiovascular diseases such as coronary artery diseases (CAD) and myocardial
infarction (MI). Subsequently, it has been demonstrated to reduce the morbidity and
mortality rate of these diseases. Besides the beneficial effects, ASA has the potential to
provoke some allergic reactions, particularly in patients with CAD. According to
previous reports, in 1.5-2.6% of the subjects with CVD treated with ASA, aspirinexacerbated
respiratory disease or chronic idiopathic urticaria were observed. In this
book chapter, we aimed to summarize all-new achievements and novel findings of
recent clinical advances related to the desensitization approaches following aspirin
consumption in patients with CADs

Keywords:

Acetylsalicylic Acid, Allergic Reactions, Anti-Platelet Effects, Antithrombotic effect, Aspirin (ASA), Aspirin Challenge, Aspirin Desensitization, Aspirin-Induced Exacerbated Respiratory Disease (AERD), Cardiovascular Disease (CVD), Clinical Advances, Clinical Trials, Coronary Artery Diseases (CAD), Cyclooxygenase (COX), Hypersensitivity, Leukotriene, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Prostaglandins, Rapid Desensitization, Sensitivity, Slow Desensitization.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books

Cite as